Company Filing History:
1 out of 3,384 
1 out of 1,455 
Years Active: 2014
Title: The Innovative Contributions of Carlos Garcia-Echeverria
Introduction
Carlos Garcia-Echeverria is a notable inventor based in Paris, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target cancer treatment. His work has garnered attention for its potential therapeutic applications.
Latest Patents
One of his key patents is titled "Spiro-oxindole MDM2 antagonists." This patent describes compounds, compositions, and methods that relate to spiro-oxindoles functioning as antagonists of the interaction between p53 and MDM2. These compounds are being explored for their use as therapeutics in treating cancer and other diseases. Carlos holds 1 patent in this area.
Career Highlights
Throughout his career, Carlos has worked with prestigious institutions, including the University of Michigan and Sanofi. His experience in these organizations has allowed him to advance his research and contribute to significant innovations in medicinal chemistry.
Collaborations
Carlos has collaborated with esteemed colleagues such as Shaomeng Wang and Wei Sun. These partnerships have further enriched his research and development efforts in the field.
Conclusion
Carlos Garcia-Echeverria's work exemplifies the impact of innovative thinking in medicinal chemistry. His contributions, particularly in cancer therapeutics, highlight the importance of research and collaboration in advancing healthcare solutions.